Scientists develop a marker for therapy response in acute myeloid leukemia
With the combination of the drugs Venetoclax and 5-Azacitidine, a new, effective and more tolerable alternative to chemotherapy for the treatment of AML has been available for several years. But for some patients, the drug combination does not work.
Baden Wüberg Alexander Waclawiczek Aino Maija Lepp Andreas Trumpp Emily Henderson Heidelberg Stem Cell Institute
Source: news-medical.net